Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group Study

Robert P. Whitehead, Kenneth J. Kopecky, Michael K. Samson, John J. Costanzi, Ronald B. Natale, Lynn G. Feun, Evan M Hersh, John J. Rinehart

Research output: Contribution to journalArticle

39 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1250-1252
Number of pages3
JournalJournal of the National Cancer Institute
Volume83
Issue number17
StatePublished - Sep 4 1991

Fingerprint

Drug Dose Response Relationship
Recombinant proteins
Interleukin
Oncology
Melanoma
Drug Evaluation
Recombinant Proteins
Intravenous Injections
Interleukin-2
Human
Recombinant

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging

Cite this

Whitehead, R. P., Kopecky, K. J., Samson, M. K., Costanzi, J. J., Natale, R. B., Feun, L. G., ... Rinehart, J. J. (1991). Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group Study. Journal of the National Cancer Institute, 83(17), 1250-1252.

Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma : Southwest Oncology Group Study. / Whitehead, Robert P.; Kopecky, Kenneth J.; Samson, Michael K.; Costanzi, John J.; Natale, Ronald B.; Feun, Lynn G.; Hersh, Evan M; Rinehart, John J.

In: Journal of the National Cancer Institute, Vol. 83, No. 17, 04.09.1991, p. 1250-1252.

Research output: Contribution to journalArticle

Whitehead, RP, Kopecky, KJ, Samson, MK, Costanzi, JJ, Natale, RB, Feun, LG, Hersh, EM & Rinehart, JJ 1991, 'Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group Study', Journal of the National Cancer Institute, vol. 83, no. 17, pp. 1250-1252.
Whitehead, Robert P. ; Kopecky, Kenneth J. ; Samson, Michael K. ; Costanzi, John J. ; Natale, Ronald B. ; Feun, Lynn G. ; Hersh, Evan M ; Rinehart, John J. / Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma : Southwest Oncology Group Study. In: Journal of the National Cancer Institute. 1991 ; Vol. 83, No. 17. pp. 1250-1252.
@article{579cf06b3aa5474b95949541323d5779,
title = "Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group Study",
author = "Whitehead, {Robert P.} and Kopecky, {Kenneth J.} and Samson, {Michael K.} and Costanzi, {John J.} and Natale, {Ronald B.} and Feun, {Lynn G.} and Hersh, {Evan M} and Rinehart, {John J.}",
year = "1991",
month = "9",
day = "4",
language = "English (US)",
volume = "83",
pages = "1250--1252",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma

T2 - Southwest Oncology Group Study

AU - Whitehead, Robert P.

AU - Kopecky, Kenneth J.

AU - Samson, Michael K.

AU - Costanzi, John J.

AU - Natale, Ronald B.

AU - Feun, Lynn G.

AU - Hersh, Evan M

AU - Rinehart, John J.

PY - 1991/9/4

Y1 - 1991/9/4

UR - http://www.scopus.com/inward/record.url?scp=0025947455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025947455&partnerID=8YFLogxK

M3 - Article

C2 - 1870152

AN - SCOPUS:0025947455

VL - 83

SP - 1250

EP - 1252

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 17

ER -